Brewin Dolphin LTD Corbus Pharmaceuticals Holdings, Inc. Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Nov 09, 2023
SELL
$6.6 - $7.8 $21,120 - $24,960
-3,200 Closed
0 $0
Q1 2019

Nov 09, 2023
SELL
$5.76 - $8.95 $7,176 - $11,151
-1,246 Reduced 28.03%
3,200 $22.2 Million
Q2 2018

Nov 09, 2023
BUY
$5.05 - $6.8 $22,452 - $30,232
4,446 New
4,446 $22.5 Million

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $1.79B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email